Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma
Crossref DOI link: https://doi.org/10.1038/srep06855
Published Online: 2014-10-31
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Tiehong
Shen, Hongchang
Dong, Wei
Qu, Xiao
Liu, Qi
Du, Jiajun
Text and Data Mining valid from 2014-10-31
Version of Record valid from 2014-10-31
Article History
Received: 30 June 2014
Accepted: 13 October 2014
First Online: 31 October 2014
Competing interests
: The authors declare no competing financial interests.